Back to results
US 2006/0188576 A1Published application
Pirenzepine ophthalmic gel
OwnerHarun Takruriinventor
Life of this patent
Estimating the term…
Abstract
It is a primary object of the present invention to provide an aqueous ophthalmic formulation, for treating myopia, comprising pirenzepine in combination with a pharmaceutically acceptable gel carrier.
Claims18
An aqueous ophthalmic gel formulation for the treatment of myopia comprising pirenzepine and an amount of gelling agent effective to form an aqueous gel, said gel having a Brookfield RVDV viscosity of from about 10,000 to about 300,000 cps at about 20° C. and sheer rate of 1 s−1, wherein said gelling agent is a water soluble cellulose derivative.
The method of the claim 17 wherein said autoclaving step is conducted under nitrogen.
Dependencies are inferred from the claim text.